Status:
RECRUITING
Evaluation of Effectiveness and Safety of Ultimaster™ Tansei™ Stent in Routine Clinical Practice
Lead Sponsor:
Duk-Woo Park, MD
Collaborating Sponsors:
CardioVascular Research Foundation, Korea
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
19+ years
Brief Summary
This study is to evaluate the effectiveness and safety of Ultimaster Tansei stent in the "real-world" daily practice.
Eligibility Criteria
Inclusion
- Patients ≥ 19 years old
- Patients receiving Ultimaster™ Tansei™ stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion
- Patients with a mixture of other drug-eluting stents (DESs)
- Terminal illness with life-expectancy ≤1 year.
- Patients with cardiogenic shock
Key Trial Info
Start Date :
September 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04443530
Start Date
September 17 2020
End Date
December 31 2030
Last Update
December 24 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Gangwon National Univ. Hospital
Chuncheon, South Korea
2
Daegu Catholic University Medical Center
Daegu, South Korea
3
Keimyung University Dongsan Medical Center
Daegu, South Korea
4
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea